D-Day Approaches For Bayer’s Asundexian Phase III Plans

Factor XIa Inhibitor Impressive So Far

 
• By Kevin Grogan
  
Bayer cross
• Source: Bayer
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business